Replies to post #712490 on NorthWest Biotherapeutics Inc (NWBO)

[StonkMaster]

My depressing yet realistic guess:

MTD dismissed: no significant SP movement. Maybe a temporary spike to get us out of this dreaded range, but nothing that holds. Maybe mid 40s and back.

MHRA approval: my guess is we stay sub-$1 if we get approval news in a vacuum. If they announce anything else of significance along side it, then all bets are off.

If MTD and approval are back to back, maybe we get up and over $1.

IMO the potential for a short squeeze or the "Apes" helping out are next to nill.

Let me end by saying I hope I'm wrong and you're right :)

[jesster64]

oh for the luvva pete, here we go again with the apes, with a whistleblower, short squeeze, what Les meant, etc....volume says no one knows anything and is in a holding pattern. Upon approval, I would guess over $2 a share, at least thats where we were on anticipation of TLD release.. Later in the fall, between mid sept and late oct, I would guess they would announce future plans for dc vax, FDA submittal, partnerships, more trials, possible merger and uplisting. If they dont, then mngmt should just retire. Just my take, without any hail marys.
MTD is a wild card, but not putting any faith in the lawsuit. As for merck, why go exclusive since keytruda patent expires in 3 years? Then the combo would belong solely to nwbo. A lot of bio in the news lately. NWBO should go back to hiring a PR firm. The big biz show will not cut it. Have a nice day.